Rambam Medical Center — Haifa

Public research footprint of Rambam Medical Center, compiled from the ClinicalTrials.gov public registry.

673

Registered studies

111

Active

Recruiting now

395

Completed

Stopped or withdrawn

Most-studied conditions

Crohn's Disease · Non-Muscle Invasive Bladder Neoplasms · Resectable Pancreatic Acinar Cell Carcinoma · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Recently updated registry entries

NCT06097260 — Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for… (Terminated)
NCT04858334 — APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following… (Recruiting)
NCT04802759 — A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Rambam Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.